Mannkind logo

Mannkind Share Price Today

(NASDAQ: MNKD)

Mannkind share price is $5.15 & ₹447.89 as on 6 Mar 2025, 2.30 'hrs' IST

$5.15

Market is closed - opens 8 PM, 06 Mar 2025

View live Mannkind share price in Dollar and Rupees. Guide to invest in Mannkind stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Mannkind, along with analyst recommendations, forecasts, and comprehensive financials.

Mannkind share price movements

  • Today's Low: $5.09
    Today's High: $5.19

    Day's Volatility :2.02%

  • 52 Weeks Low: $3.97
    52 Weeks High: $7.63

    52 Weeks Volatility :47.97%

Mannkind (MNKD) Returns

PeriodMannkind Corp.Sector (Health Care)Index (Russel 2000)
3 Months
-23.48%
2.1%
0.0%
6 Months
-14.59%
-4.1%
0.0%
1 Year
7.29%
2.2%
0.0%
3 Years
64.54%
11.8%
-11.6%

Mannkind (MNKD) Key Statistics

in dollars & INR

Previous Close
$5.15
Open
$5.14
Today's High
$5.19
Today's Low
$5.085
Market Capitalization
$1.6B
Today's Volume
$812.4K
52 Week High
$7.63
52 Week Low
$3.97
Revenue TTM
$267.2M
EBITDA
$63.7M
Earnings Per Share (EPS)
$0.08
PE Ratio
70.63
Profit Margin
8.07%
Quarterly Earnings Growth YOY
5.25%
Return On Equity TTM
0.0%

How to invest in Mannkind Stock (MNKD) from India?

It is very easy for Indian residents to invest directly in Mannkind from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mannkind stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mannkind or MNKD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mannkind or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mannkind shares which would translate to 0.169 fractional shares of Mannkind as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mannkind, in just a few clicks!

Returns in Mannkind (MNKD) for Indian investors in Rupees

The Mannkind stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mannkind investment value today

Current value as on today

₹1,12,254

Returns

₹12,254

(+12.25%)

Returns from Mannkind Stock

₹7,292 (+7.29%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Mannkind (MNKD)

-34%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Mannkind Stock from India on INDmoney has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Mannkind

  • BlackRock Inc

    7.90%

  • Vanguard Group Inc

    5.29%

  • State Street Corp

    3.28%

  • venBio Select Advisor LLC

    2.88%

  • Nitorum Capital, L.P.

    2.88%

  • Geode Capital Management, LLC

    2.10%

Analyst Recommendation on Mannkind

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Mannkind(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Mannkind Stock (MNKD)

What analysts predicted

Upside of 94.17%

Target:

$10.00

Current:

$5.15

Insights on Mannkind Stock (Ticker Symbol: MNKD)

  • Price Movement

    In the last 3 years, MNKD stock has moved up by 71.7%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 70.07M → 76.77M (in $), with an average increase of 8.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 11.55M → 7.42M (in $), with an average decrease of 35.7% per quarter
  • MNKD vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 53.9%
  • Price to Sales

    ForMNKD every $1 of sales, investors are willing to pay $5.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Mannkind Technicals Summary

Sell

Neutral

Buy

Mannkind is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Mannkind (MNKD) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mannkind Corp. logo
-7.54%
-14.59%
7.29%
64.54%
315.32%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mannkind Corp. logo
70.63
70.63
-0.23
0.11
0.0
0.09
NA
-0.76
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mannkind Corp. logo
Buy
$1.6B
315.32%
70.63
8.07%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Mannkind

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. The company's product pipeline also includes Tyvaso DPI (Treprostinil), an inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; MNKD-101, a nebulized formulation of clofazimine, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, for the treatment of idiopathic pulmonary fibrosis (IPF). In addition, it has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; co-promotion agreement with Vertice Pharma to promote Thyquidity; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; and license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.
Organization
Mannkind
Employees
403
CEO
Dr. Michael E. Castagna Pharm.D.
Industry
Health Technology

Management People of Mannkind

NameTitle
Dr. Michael E. Castagna Pharm.D.
CEO & Director
Ms. Lauren M. Sabella
Executive Vice President of Operations
Dr. David B. Thomson J.D., Ph.D.
Executive VP, General Counsel & Secretary
Dr. Stuart A. Tross Ph.D.
Executive Vice President of Human Resources
Mr. Christopher B. Prentiss M.B.A.
Chief Financial Officer
Mr. Sanjay Singh M.B.A.
Executive Vice President of Technical Operations
Ms. Rosabel Realica Alinaya CPA
VP of Investor Relations & Treasury
Mr. John F. Bedard
Senior Vice President of Worldwide Regulatory Affairs
Mr. James Patrick McCauley Jr., J.D., M.B.A.
Chief Commercial Officer
Dr. Burkhard Blank M.D.
Executive VP of Research & Development and Chief Medical Officer

Important FAQs about investing in MNKD Stock from India :

What is Mannkind share price today?

Mannkind share price today stands at $5.15, Open: $5.14 ; Previous Close: $5.15 ; High: $5.19 ; Low: $5.09 ; 52 Week High: $7.63 ; 52 Week Low: $3.97.

The stock opens at $5.14, after a previous close of $5.15. The stock reached a daily high of $5.19 and a low of $5.09, with a 52-week high of $7.63 and a 52-week low of $3.97.

Can Indians buy Mannkind shares?

Yes, Indians can invest in the Mannkind (MNKD) from India.

With INDmoney, you can buy Mannkind at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Mannkind at zero transaction cost.

How can I buy Mannkind shares from India?

It is very easy to buy Mannkind from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mannkind (MNKD) be purchased?

Yes, you can buy fractional shares of Mannkind with INDmoney app.

What are the documents required to start investing in Mannkind stocks?

To start investing in Mannkind, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Mannkind Stock (MNKD)?

Today’s highest price of Mannkind (MNKD) is $5.19.

Today’s lowest price of Mannkind (MNKD) is $5.09.

What is today's market capitalisation of Mannkind?

Today's market capitalisation of Mannkind MNKD is 1.6B

What is the 52 Week High and Low Range of Mannkind Stock (MNKD)?

  • 52 Week High

    $7.63

  • 52 Week Low

    $3.97

What are the historical returns of Mannkind (MNKD)?

  • 1 Month Returns

    -7.54%

  • 3 Months Returns

    -14.59%

  • 1 Year Returns

    7.29%

  • 5 Years Returns

    315.32%

Who is the Chief Executive Officer (CEO) of Mannkind ?

Dr. Michael E. Castagna Pharm.D. is the current Chief Executive Officer (CEO) of Mannkind.